JPH0413357B2 - - Google Patents
Info
- Publication number
- JPH0413357B2 JPH0413357B2 JP60012477A JP1247785A JPH0413357B2 JP H0413357 B2 JPH0413357 B2 JP H0413357B2 JP 60012477 A JP60012477 A JP 60012477A JP 1247785 A JP1247785 A JP 1247785A JP H0413357 B2 JPH0413357 B2 JP H0413357B2
- Authority
- JP
- Japan
- Prior art keywords
- biopterin
- added
- erythro
- amines
- catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
〔産業上の利用分野〕
本発明は式()
で表わされる(6R)−テトラヒドロ−L−バイオ
プテリンの製造法、更に詳細には、テトラヒドロ
−L−バイオプテリンの6R体を高い比率で得る
ことができる工業的な製造法に関する。
〔従来の技術及び問題点〕
テトラヒドロ−L−バイオプテリン(以下
「BPH4」と略称する)には6位の水素の立体配
置により6R体と6S体の異性体が存在する
〔Furrer,H.J.ら:Helv.Chim.Acta,62,2577
(1979)〕。
そして、なかんずく(6R)−BPH4はフエニル
アラニン水酸化酵素の補酵素であると同時に、他
の芳香族アミノ酸水酸化酵素の補酵素でもある。
それゆえ、その欠乏は神経伝達物質であるセロ
トニン、ドーパミン、ノルアドレナリン、アドレ
ナリンなどを欠乏させ、重篤な神経症状をおこさ
せる。また、先天性代謝異常症の一つである悪性
高フエニルアラニン血症はきそんの薬物療法では
容易には治療できない難病であるが、これは
(6R)−BPH4の欠乏によりフエニルアラニンのチ
ロシンへの変換が阻害されるために起ることが知
られている。
悪性高フエニルアラニン血症の治療に(6R)−
BPH4の投与が考えられるが、そのためには本品
を高純度に経済的に製造する方法の開発が望まれ
ている。
テトラヒドロ−L−バイオプテリンを製造する
方法としては、L−エリスロ−バイオプテリンを
酵素的あるいは化学的に還元する方法が知られて
いる。就中酵素法は6R体のみが得られるという
利点はあるが、装置及び操作が煩雑であると共に
製造コストが高く工業的方法としては不利なるを
免れない。一方化学的方法によると、6R体と6S
体の混合物を生じ、これは分割しなければならな
いが、この分割は極めて困難であり、現在その有
利な分割法は知られていない。
従つて、従来から(6R)−BPH4を高比率で、
出来ればこれを選択的に合成する方法の開発が望
まれているが、未だ満足な方法は見出されていな
い。
〔問題点を解決するための手段〕
斯かる実情において、本発明者は鋭意研究を行
つた結果、L−エリスロ−バイオプテリン又はそ
のアシル誘導体を白金黒を触媒として特定の条件
下接触還元すれば、不斉合成率R/Sを著しく高
めることができ、しかもこのような高いR/S値
のものであれば容易に(6R)−BPH4を分離収得
できることを見出し、本発明を完成した。
従つて、本発明は、L−エリスロ−バイオプテ
リン又はそのアシル誘導体()を白金黒を触媒
としてアミン類の存在下PH10〜13で接触還元し、
アシル基が存在する場合にはこれを脱離して
(6R)−テトラヒドロ−L−バイオプテリン()
を製造する方法であり、これは次の反応式によつ
て示される。
(式中、RはH又はアシル基を示す)
本発明を実施するには、L−エリスロ−バイオ
プテリン又はそのアシル誘導体()をアミン類
でPH10〜13に調整した水、アルコール系又はこれ
らの混合溶媒中で白金黒を触媒として接触還元す
る。アルコール系溶媒としては、メタノール、エ
タノール、メチルセルソルブ、エチレングリコー
ル等が挙げられる。アミン類としては、メチルア
ミン、エチルアミン、シクロヘキシルアミン等の
第1級アミン、ジメチルアミン、ジエチルアミ
ン、ピペリジン、モルホリン等の第2級アミン、
トリメチルアミン、トリエチルアミン等の第3級
アミン、テトラメチルアンモニウムヒドロキシ
ド、テトラエチルアンモニウムヒドロキシド、ベ
ンジルトリメチルアンモニウムヒドロキシド等の
第4級アミン等が挙げられる。このアミン類はPH
10〜13になるように添加すればよく、PHがこれよ
り低くなると、不斉合成率が低下し、高くなると
不斉合成率R/S及び収率が共に低下する。
触媒は種々の触媒、就中白金系触媒の中でも白
金黒が特異的であり、他のものに比較し極めて高
い不斉合成率R/Sを示す。
本発明方法は通常の接触還元の操作によつて行
うことができ、反応温度は−10℃〜50℃が、H2
圧力は1Kg/cm2以上、特に1〜100Kg/cm2が好ま
しい。
このようにするとき、不斉合成率R/S約7以
上にて(6S)−BPH4又はそのアシル誘導体を得
ることができる。アシル基の一部は上記反応によ
つて除去されるが、まだこれが残存する場合に
は、塩酸等によつて加水分解することにより容易
に除去される。この生成物を再結晶することによ
り高純度の(6R)−BPH4を単離収得することが
できる。
〔発明の効果〕
叙上の如く、本発明は従来化学的合成法では製
造困難であつた(6R)−BPH4を高い不斉合成率
R/Sでしかも高収率にて製造することに成功し
た極めて優れた発明である。
〔実施例〕
次に実施例を挙げて説明する
実施例 1
L−エリスロ−バイオプテリン1.0g(4.22ミ
リモル)、白金ブラツク0.20gを水95mlに加え、
これに10%テトラエチルアンモニウムヒドロキシ
ドを加え、PH=12.0に調整した。これをオートク
レーブに入れ、H2圧力100Kg/cm2、温度0〜5
℃、回転数1000r.p.m.で撹拌し20時間反応させ
た。反応物に濃塩酸5mlを加え、触媒を過して
除き、減圧下浴温35℃以下で濃縮し、残留物を
3N塩酸とエタノールの混合触媒より再結晶した。
融点244.5℃(分解)の白色結晶、(6R)−
BPH42HClを1.13g得た。
元素分析値 理論値(%) 分析値(%)
C9H17Cl2N5O3
C 34.41 34.50
H 5.45 5.41
N 22.29 22.58
旋光度〔α〕25 D:−6.39゜(C,0.68;0.1N HCl)
1H−NMR(CD3OD−D2O):4.10−3.70(5H,
m,H−C(6,7,1′,2′)),1.40(3H,
d,J=6Hz,H−C(3′))
実施例 2
L−エリスロ−バイオプテリン1.0g(4.22ミ
リモル)、白金ブラツク0.20gを水95mlに加え、
これに第1表の塩基を加え所定PHに調整した。こ
れをオートクレーブに入れ、H2圧力100Kg/cm2、
温度0〜5℃、回転数1000r.p.mで撹拌し20時間
反応させた。反応物に濃塩酸5mlを加え、触媒を
過して除き、この液部について高速液体クロ
マトグラフイーで分析し、それぞれのR/S比お
よび(R体+S体)の収率をもとめた。その結果
は第1表の通りである。
高速液体クロマトグラフイー測定条件
検出器:紫外吸光光度計(測定波長:
275nm)
カラム:Partisil−10SCX,4.5×250mm
移動相:30mMリン酸アンモニウム・3mM
亜硫酸アンモニウム(PH=3.0)
流 量:2ml/min
[Industrial Application Field] The present invention is based on the formula () The present invention relates to a method for producing (6R)-tetrahydro-L-biopterin represented by the formula, and more particularly to an industrial production method capable of obtaining a high proportion of 6R-biopterin. [Prior art and problems] Tetrahydro-L-biopterin (hereinafter abbreviated as " BPH4 ") has isomers of 6R and 6S depending on the configuration of hydrogen at the 6-position [Furrer, HJ et al. :Helv.Chim.Acta, 62, 2577
(1979)]. Above all, (6R)-BPH 4 is a coenzyme of phenylalanine hydroxylase, as well as a coenzyme of other aromatic amino acid hydroxylases. Therefore, its deficiency leads to a deficiency of neurotransmitters such as serotonin, dopamine, noradrenaline, and adrenaline, resulting in serious neurological symptoms. In addition, malignant hyperphenylalaninemia, which is one of the inborn errors of metabolism, is an incurable disease that cannot be easily treated with conventional drug therapy. It is known that this occurs because the conversion to tyrosine is inhibited. For the treatment of malignant hyperphenylalaninemia (6R)-
Administration of BPH 4 is considered, but for this purpose it is desired to develop a method to economically produce this product with high purity. As a method for producing tetrahydro-L-biopterin, a method of enzymatically or chemically reducing L-erythro-biopterin is known. Among them, the enzymatic method has the advantage that only the 6R form can be obtained, but it is disadvantageous as an industrial method because it requires complicated equipment and operations and has a high production cost. On the other hand, according to chemical methods, 6R and 6S
This results in a mixture of bodies, which must be divided, but this division is extremely difficult and no advantageous division method is currently known. Therefore, conventionally, (6R)-BPH 4 is used at a high ratio,
If possible, it would be desirable to develop a method for selectively synthesizing this, but no satisfactory method has yet been found. [Means for Solving the Problem] Under these circumstances, the present inventor has conducted extensive research and found that if L-erythro-biopterin or its acyl derivative is catalytically reduced using platinum black as a catalyst under specific conditions. The present invention was completed based on the discovery that the asymmetric synthesis rate R/S can be significantly increased, and that (6R)-BPH 4 can be easily separated and obtained with such a high R/S value. Therefore, the present invention provides catalytic reduction of L-erythro-biopterin or its acyl derivative () at pH 10 to 13 in the presence of amines using platinum black as a catalyst,
If an acyl group exists, it is removed to form (6R)-tetrahydro-L-biopterin ().
This is a method for producing , which is shown by the following reaction formula. (In the formula, R represents H or an acyl group.) To carry out the present invention, L-erythro-biopterin or its acyl derivative () is mixed with water, alcohol-based, or alcohol-based water whose pH is adjusted to 10 to 13 with amines. Catalytic reduction is carried out in a mixed solvent using platinum black as a catalyst. Examples of alcoholic solvents include methanol, ethanol, methylcellosolve, ethylene glycol, and the like. Examples of amines include primary amines such as methylamine, ethylamine, and cyclohexylamine; secondary amines such as dimethylamine, diethylamine, piperidine, and morpholine;
Examples include tertiary amines such as trimethylamine and triethylamine, and quaternary amines such as tetramethylammonium hydroxide, tetraethylammonium hydroxide, and benzyltrimethylammonium hydroxide. These amines have a pH of
It may be added so that the pH becomes 10 to 13. When the pH is lower than this, the asymmetric synthesis rate decreases, and when it becomes higher, both the asymmetric synthesis rate R/S and the yield decrease. Among various catalysts, especially platinum-based catalysts, platinum black is unique and exhibits an extremely high asymmetric synthesis rate R/S compared to other catalysts. The method of the present invention can be carried out by ordinary catalytic reduction operations, and the reaction temperature is -10°C to 50°C, but H 2
The pressure is preferably 1 Kg/cm 2 or more, particularly 1 to 100 Kg/cm 2 . When doing so, (6S)-BPH 4 or its acyl derivative can be obtained at an asymmetric synthesis rate R/S of about 7 or more. A part of the acyl group is removed by the above reaction, but if it still remains, it is easily removed by hydrolysis with hydrochloric acid or the like. By recrystallizing this product, highly pure (6R)-BPH 4 can be isolated and obtained. [Effects of the invention] As described above, the present invention makes it possible to produce (6R)-BPH 4 , which has been difficult to produce by conventional chemical synthesis methods, with a high asymmetric synthesis rate R/S and in a high yield. This is an extremely successful invention. [Example] Next, Example 1 will be described with reference to examples: 1.0 g (4.22 mmol) of L-erythro-biopterin and 0.20 g of platinum black were added to 95 ml of water,
10% tetraethylammonium hydroxide was added to this to adjust the pH to 12.0. Put this in an autoclave, H2 pressure 100Kg/ cm2 , temperature 0-5
The mixture was stirred at a temperature of 1000 rpm and allowed to react for 20 hours. Add 5 ml of concentrated hydrochloric acid to the reaction mixture, remove the catalyst by filtration, and concentrate under reduced pressure at a bath temperature of 35°C or less to remove the residue.
It was recrystallized from a mixed catalyst of 3N hydrochloric acid and ethanol. White crystals with a melting point of 244.5℃ (decomposition), (6R)−
1.13g of BPH 4 2HCl was obtained. Elemental analysis value Theoretical value (%) Analytical value (%) C 9 H 17 Cl 2 N 5 O 3 C 34.41 34.50 H 5.45 5.41 N 22.29 22.58 Optical rotation [α] 25 D : -6.39° (C, 0.68; 0.1N HCl) 1 H−NMR (CD 3 OD−D 2 O): 4.10−3.70 (5H,
m, H-C (6, 7, 1', 2')), 1.40 (3H,
d, J = 6 Hz, H-C (3')) Example 2 1.0 g (4.22 mmol) of L-erythro-biopterin and 0.20 g of platinum black were added to 95 ml of water,
The bases shown in Table 1 were added to this and the pH was adjusted to a predetermined value. Put this in an autoclave, H2 pressure 100Kg/ cm2 ,
The mixture was stirred at a temperature of 0 to 5° C. and a rotation speed of 1000 rpm, and reacted for 20 hours. 5 ml of concentrated hydrochloric acid was added to the reaction mixture, the catalyst was removed by filtration, and the liquid portion was analyzed by high performance liquid chromatography to determine the respective R/S ratios and yields of (R-isomer + S-isomer). The results are shown in Table 1. High performance liquid chromatography measurement conditions Detector: Ultraviolet absorption photometer (measurement wavelength:
275nm) Column: Partisil-10SCX, 4.5 x 250mm Mobile phase: 30mM ammonium phosphate, 3mM
Ammonium sulfite (PH=3.0) Flow rate: 2ml/min
【表】
*実施例−1
実施例 3
塩基として、トリエチルアミン、ジエチルアミ
ン、エチルアミン及びテトラエチルアンモニウム
ヒドロオキシドを使用してPHを12に調整し、反応
温度とH2圧力を変えて実施例2と同様に操作し
た。その結果は第2〜5表のとおりである。[Table] *Example-1
Example 3 The same procedure as in Example 2 was carried out, using triethylamine, diethylamine, ethylamine and tetraethylammonium hydroxide as bases, adjusting the pH to 12, and changing the reaction temperature and H2 pressure. The results are shown in Tables 2-5.
【表】【table】
【表】【table】
【表】【table】
【表】
実施例 4
L−エリスロ−バイオプテリン20mg、白金黒4
mgを第6表の溶媒2mlに加え、第6表の塩基を加
えて所定PHに調整した。これをオートクレーブに
入れ、H2圧力100Kg/cm2、第6表の温度で20時間
反応させた。反応物を実施例2と同様にし操作し
て、不斉合成率R/Sと(R体+S体)収率を測
定した。その結果は第6表のとおりである。[Table] Example 4 L-erythro-biopterin 20 mg, Shirogane Black 4
mg was added to 2 ml of the solvent shown in Table 6, and the base shown in Table 6 was added to adjust the pH to a predetermined value. This was placed in an autoclave and reacted for 20 hours at a H 2 pressure of 100 Kg/cm 2 and a temperature shown in Table 6. The reaction product was operated in the same manner as in Example 2, and the asymmetric synthesis rate R/S and (R-isomer+S-isomer) yield were measured. The results are shown in Table 6.
【表】
実施例 5
水又は有機溶媒2mlにトリアセチル−L−エリ
スロ−バイオプテリン20mg、白金黒4mg及び塩基
を加え、オートクレーブ中で、H2気圧100Kg/
cm2、温度20℃にて20時間反応させた。反応物に
3N塩酸20mlを加え、触媒を去し、液1.5mlに
濃塩酸0.5mlを加え、3日間放置して脱アセチル
化した。これを実施例2と同条件下高速液体クロ
マトグラフイーで分析し、R/Sと(R体+S
体)収率を測定した。その結果は第7表のとおり
である。[Table] Example 5 20 mg of triacetyl-L-erythro-biopterin, 4 mg of platinum black, and a base were added to 2 ml of water or an organic solvent, and the mixture was heated in an autoclave with 100 kg of H 2 atm.
cm 2 and a temperature of 20°C for 20 hours. to the reactant
20 ml of 3N hydrochloric acid was added to remove the catalyst, 0.5 ml of concentrated hydrochloric acid was added to 1.5 ml of the solution, and the mixture was left to stand for 3 days for deacetylation. This was analyzed by high performance liquid chromatography under the same conditions as in Example 2, and R/S and (R body + S
body) yield was measured. The results are shown in Table 7.
【表】【table】
Claims (1)
ル誘導体を白金黒を触媒としてアミン類の存在下
PH10〜13で接触還元し、アシル基が存在する場合
にはこれを脱離することを特徴とする(6R)−テ
トラヒドロ−L−バイオプテリンの製造法。 2 反応を水/及びアルコール系溶媒中行うこと
を特徴とする特許請求の範囲第1項記載の製造
法。[Claims] 1 L-erythro-biopterin or its acyl derivative in the presence of amines using platinum black as a catalyst
A method for producing (6R)-tetrahydro-L-biopterin, which comprises performing catalytic reduction at pH 10 to 13 and eliminating acyl groups, if present. 2. The production method according to claim 1, wherein the reaction is carried out in water/alcoholic solvent.
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60012477A JPS61172876A (en) | 1985-01-28 | 1985-01-28 | Production of (6r)-tetrahydro-l-biopterin |
| US06/824,288 US4713454A (en) | 1985-01-28 | 1986-01-23 | Preparation process of (6R)-tetrahydro-L-biopterin |
| CA000500218A CA1262347A (en) | 1985-01-28 | 1986-01-23 | Preparation process of (6r)-tetrahydro-l-biopterin |
| AT86100944T ATE66229T1 (en) | 1985-01-28 | 1986-01-24 | PROCESS FOR THE PRODUCTION OF (6R)-TETRAHYDRO-L-BIOPTERIN. |
| EP86100944A EP0191335B1 (en) | 1985-01-28 | 1986-01-24 | Preparation process of (6r)-tetrahydro-l-biopterin |
| DE8686100944T DE3680800D1 (en) | 1985-01-28 | 1986-01-24 | METHOD FOR PRODUCING (6R) -TETRAHYDRO-L-BIOPTERIN. |
| AU52720/86A AU581052B2 (en) | 1985-01-28 | 1986-01-24 | Preparation process of (6R)-tetrahydro-L-biopterin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60012477A JPS61172876A (en) | 1985-01-28 | 1985-01-28 | Production of (6r)-tetrahydro-l-biopterin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8164213A Division JP2711828B2 (en) | 1996-06-25 | 1996-06-25 | Method for producing (6R) -tetrahydro-L-biopterin hydrochloride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61172876A JPS61172876A (en) | 1986-08-04 |
| JPH0413357B2 true JPH0413357B2 (en) | 1992-03-09 |
Family
ID=11806461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60012477A Granted JPS61172876A (en) | 1985-01-28 | 1985-01-28 | Production of (6r)-tetrahydro-l-biopterin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61172876A (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60178887A (en) * | 1984-02-23 | 1985-09-12 | Kanegafuchi Chem Ind Co Ltd | Preparation of 5,6,7,8-tetrahydro-l-biopterin |
| CN1894251B (en) * | 2003-11-17 | 2011-06-29 | 默克和西伊公司 | Crystalline forms of (6R)-l-erythro-tetrahydrobiopterin dihydrochloride |
| ATE415403T1 (en) * | 2005-04-14 | 2008-12-15 | Shiratori Pharm | METHOD FOR PRODUCING ALPHAFORM CRYSTALS OF SAPROPTERINE HYDROCHLORIDE |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60142959A (en) * | 1983-12-28 | 1985-07-29 | Otsuka Pharmaceut Co Ltd | Quinoline derivative |
-
1985
- 1985-01-28 JP JP60012477A patent/JPS61172876A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61172876A (en) | 1986-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0191335B1 (en) | Preparation process of (6r)-tetrahydro-l-biopterin | |
| Sasai et al. | Syntheses of (S)-(−)-pindolol and [3′-13C]-(R)-(−)-pindolol utilizing a lanthanum-lithium-(R)-BINOL ((R)-LLB) catalyzed nitroaldol reaction | |
| JPH0288569A (en) | Oxidation of 5-hydroxymethylfuurfural | |
| EP4349995A1 (en) | Method for using reduction to prepare (s)-nicotine | |
| EP0156330B1 (en) | Sulfate of 5,6,7,8-tetrahydro-l-erythro-biopterin and process for preparing the same | |
| CN113444108B (en) | 1, 4-sulfur bridge polycyclic compound containing dihydrobenzofuran structure, preparation method and application thereof | |
| JPH01308243A (en) | Production method of 4-demethoxydaunomycinone | |
| JP2711828B2 (en) | Method for producing (6R) -tetrahydro-L-biopterin hydrochloride | |
| CN119019320B (en) | Preparation method of piperidine compound with antiplatelet activity | |
| CN112479968B (en) | A kind of synthetic method of catalyzing hydroamination reaction to prepare 2-methylpyrrolidine compound | |
| JPH0586393B2 (en) | ||
| CN112209947A (en) | Chiral indoxazinone compound and synthesis method thereof | |
| JP2912572B2 (en) | Method for producing optically active amines | |
| SU1240354A3 (en) | Method of producing pyrbuterol dihydrochloride | |
| JPS61172876A (en) | Production of (6r)-tetrahydro-l-biopterin | |
| CN119060057B (en) | Indolocyclopentanes Compound and synthesis method thereof | |
| JP2674707B2 (en) | L-Biopterin manufacturing method | |
| CN116023357B (en) | A method for converting o-hydroxyacetophenones into chromanone compounds containing quaternary carbon centers | |
| US5550267A (en) | Process for the synthesis of haloalkylferrocenes | |
| WO2024050725A1 (en) | Methods of producing 2, 3, 5, 6-alkyl-1, 4-benzoquinones | |
| JP2995448B2 (en) | Method for producing (6S) -tetrahydro-D-neopterin | |
| JP2617329B2 (en) | Production method of optically active amino alcohol | |
| JPS62212352A (en) | Production of carnitine intermediate | |
| JPH0332553B2 (en) | ||
| KR20260004638A (en) | Selective reduction of carbon-carbon double or triple bond |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |